Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Macha Research Trust (MRT) is a premier health research institution based in Zambia, dedicated to combating malaria, HIV/AIDS, and tuberculosis through field-based scientific inquiry. Established in 2005 as a registered trust, MRT maintains a long-standing partnership with the Johns Hopkins Bloomberg School of Public Health and the Johns Hopkins Malaria Research Institute. The organization operates state-of-the-art laboratories in a rural setting, facilitating clinical trials, entomological research, and epidemiological studies. MRT's work has been pivotal in evaluating the efficacy of antimalarial interventions and vaccines, such as the RTS,S vaccine, in real-world endemic environments. By integrating community-based research with advanced molecular biology, the trust plays a vital role in the global effort to eliminate tropical diseases.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Macha Research Trust.